ENX-104

N/A

Report date: 2026/03/17 20:00:15

NME

Base Information

Drug NameENX-104

Drug Alias NameENX-104

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonists

TargetsDopamine D2 receptorDopamine D3 receptor

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsN/A

ATC CodeN/A